Skip to main content
  • Home
  •  An Expert Approach to Cardio-Renal Protection in CKD

An Expert Approach to Cardio-Renal Protection in CKD

  • CKD
  • Heart Failure

Available Credit:

  • 2.00 EBAC

Course Published On:

Course Expiry Date:

An Expert Approach to Cardio-Renal Protection in CKD
No ratings


This two part programme considers the current guideline-directed approach to chronic kidney disease (CKD) and how SGLT-2 inhibitors can be used to maximal effect. This case-based discussion is chaired by Prof James Burton (University of Leicester, UK) and includes expert insight from a world-renowned faculty, Prof David Wheeler (University College London, UK), Dr Navdeep Tangri (University of Manitoba, CA), and Prof Carol Pollock (University of Sydney, AUS).


In this dynamic series, our expert panel will unravel the complexities of CKD care in the context of a real-world patient case. Part two offers a forensic analysis of current practices, revisiting the patient case presented in part one, in reflection of recent guideline updates. The panel will provide you with evidence-based strategies for initiating pharmacological therapies that transcend the theoretical and become actionable in everyday practice.


Elevate your understanding, challenge clinical norms, and be at the forefront of CKD care. 

Support Statement

This programme is supported by an unrestricted educational grant from AstraZeneca.


In compliance with EBAC guidelines, all speakers/chairpersons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations. 


The Organising Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CME activities.

Terms & Conditions

Radcliffe Education requires contributors to our CME programmes to disclose any relevant financial relationships that have occurred within the past 12 months that could create a conflict of interest. These will be identified in the faculty section if applicable.


This programme, ‘An Expert Approach to Cardio-Renal Protection in CKD’ is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 2 hours of external CME credits. 


Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).


Through an agreement between the European Board for Accreditation of Continuing Education for Health Professionals and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website.

Instruction to Participants

There is no fee for taking part in this online learning activity.


Activities are designed to be completed within 120 minutes and must be completed by the registered user. Physicians should only claim credits for time spent on the activity. To successfully earn credit, participants must complete the activity in full in the indicated time frame.


To complete the course and claim certification participants must:


  • Read the course outline information supplied and complete pre-test questions if supplied prior to starting the activity. Users must read and study the activity in its entirety before completing the post-test questions.


  • Your results will be automatically saved and if a pass score is achieved (where applicable), you may be eligible to claim credit for the activity and receive a certificate of completion.

Target Audience

Target Audience

  • Cardiologists
  • Heart Failure Specialists
  • Nephrologists
  • Primary Care Physicians

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Recall clinical evidence and guidelines for the management of CKD patients without diabetes
  • Describe current gaps and barriers in evidence-based management for CKD without diabetes
  • Apply evidence based-management strategies to a case study
  • Use expert-led guidance to develop an optimal management approach to CKD patients without diabetes
Register now Log in





An Expert Approach to Cardio-Renal Protection in CKD Part One 1 hour James Burton (Leicester, UK) Navdeep Tangri (Winnipeg, CA) David Wheeler (London, UK) Carol Pollock (Sydney, AUS)
An Expert Approach to Cardio-Renal Protection in CKD Part Two 1 hour James Burton (Leicester, UK) Navdeep Tangri (Winnipeg, CA) David Wheeler (London, UK )
An Expert Approach to Cardio-Renal Protection in CKD.
An Expert Approach to Cardio-Renal Protection in CKD.


James Burton

University of Leicester, UK

Prof James Burton is Honorary Consultant Nephrologist and Professor of Renal Medicine and Associate Dean for Clinical Research at the University of Leicester, Leicester, UK.

View full profile


David Wheeler

University College London, London, UK

David Wheeler is Professor of Kidney Medicine at University College London and Honorary Consultant Nephrologist at the Royal Free London NHS Foundation Trust.

View full profile

Navdeep Tangri

University of Manitoba, Winnipeg, CA

Dr Navdeep Tangri is a Professor of Medicine in the Division of Nephrology at University of Manitoba, Winnipeg, CA.

View full profile

Carol Pollock

Kolling Institute of Medical Research, Sydney Medical School, University of Sydney, Royal North Shore Hospital, St Leonards, NSW, Australia

Carol Pollock is Professor of Medicine at the University of Sydney in Sydney, Australia.

View full profile
2.00 EBAC

Related Courses

Hyperkalaemia in Cardiorenal Disease – A Case Based Discussion
  • Not accredited

Learning objectives

  • Explain the relationship between sub-optimal RAASi therapy and poor cardio-renal outcomes
  • Identify patients who would benefit from anti-hyperkalaemia medications
  • Select appropriate anti-hyperkalaemia treatments across a range of patient profiles
  • Adopt anti-hyperkalaemia medications as an approach to prolong optimal RAASi therapy
  • Summarise current guideline recommendations on the use of potassium binding agents
See more